{"id":356644,"date":"2026-07-01T02:09:20","date_gmt":"2026-07-01T02:09:20","guid":{"rendered":"https:\/\/www.newsbeep.com\/us-tx\/356644\/"},"modified":"2026-07-01T02:09:20","modified_gmt":"2026-07-01T02:09:20","slug":"american-cancer-society-invests-in-ut-san-antonio-pediatric-bone-cancer-research","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us-tx\/356644\/","title":{"rendered":"American Cancer Society invests in UT San Antonio pediatric bone cancer research"},"content":{"rendered":"<p>Contact: Eileen Teves, 210-450-7239, <a href=\"https:\/\/news.uthscsa.edu\/american-cancer-society-invests-in-ut-san-antonio-pediatric-bone-cancer-research\/mailto:tevese@uthscsa.edu\" rel=\"nofollow noopener\" target=\"_blank\">tevese@uthscsa.edu<\/a><\/p>\n<p>SAN ANTONIO, June 30, 2026 \u2013 The American Cancer Society has awarded an $879,000 Research Scholar Grant to <a href=\"https:\/\/directory.uthscsa.edu\/academics\/profile\/subbarayalu\" rel=\"nofollow noopener\" target=\"_blank\">Panneerdoss Subbarayalu, PhD<\/a>, assistant professor\/research in the <a href=\"https:\/\/lsom.uthscsa.edu\/dcsa\/\" rel=\"nofollow noopener\" target=\"_blank\">Department of Cell Systems and Anatomy<\/a> at the <a href=\"https:\/\/uthscsa.edu\/medicine\/\" rel=\"nofollow noopener\" target=\"_blank\">Joe R. and Teresa Lozano Long School of Medicine<\/a> at The University of Texas at San Antonio (UT San Antonio). The four-year grant will support groundbreaking research at <a href=\"https:\/\/gccri.uthscsa.edu\/\" rel=\"nofollow noopener\" target=\"_blank\">Greehey Children\u2019s Cancer Research Institute<\/a> to develop a new targeted therapy for osteosarcoma, the most common type of bone cancer in children and adolescents.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\" wp-image-42253\" src=\"https:\/\/www.newsbeep.com\/us-tx\/wp-content\/uploads\/2026\/07\/Panneerdoss-Subbarayalu.jpg\" alt=\"\" width=\"193\" height=\"290\"\/>Panneerdoss Subbarayalu, PhD<\/p>\n<p>The American Cancer Society Research Scholar Grant is a highly competitive national award that recognizes investigators conducting innovative cancer research that has strong potential to advance cancer care and improve patient outcomes.<\/p>\n<p>Subbarayalu\u2019s research is aimed at identifying safer and more effective treatment strategies for osteosarcoma and exploring a promising therapeutic target known as Leukemia Inhibitory Factor Receptor (LIFR).<\/p>\n<p>\u201cOur work shows that LIFR plays a critical role in driving tumor growth, metastasis, treatment resistance and the survival of cancer stem cells,\u201d said Subbarayalu, the study\u2019s principal investigator. \u201cOur findings suggest that targeting LIFR may help suppress tumor growth, reduce treatment resistance and improve sensitivity to radiation therapy, potentially leading to better outcomes for young patients.\u201d<\/p>\n<p>Although current treatments combine surgery and intensive chemotherapy, nearly half of osteosarcoma patients experience relapse, often due to metastatic disease. Once the cancer spreads to the lungs or other organs, five-year survival rates drop to approximately 20 percent.<\/p>\n<p>The research team also includes co-investigators <a href=\"https:\/\/directory.uthscsa.edu\/academics\/profile\/HoughtonP\" rel=\"nofollow noopener\" target=\"_blank\">Peter Houghton, PhD<\/a>, professor in the Department of Molecular Medicine and distinguished former director of the Greehey Institute; <a href=\"https:\/\/cancer.uthscsa.edu\/doctors-and-locations\/doctors-and-clinics\/gail-tomlinson\" rel=\"nofollow noopener\" target=\"_blank\">Gail Tomlinson, MD, PhD<\/a>, professor of pediatrics, chief of pediatric hematology-oncology in the Department of Pediatrics, and co-leader of the Cancer Prevention and Screening Committee; <a href=\"https:\/\/directory.uthscsa.edu\/academics\/profile\/cheny8\" rel=\"nofollow noopener\" target=\"_blank\">Yidong Chen, PhD<\/a>, professor in the Department of Population Health Sciences and investigator with the Greehey Institute; <a href=\"https:\/\/directory.uthscsa.edu\/academics\/profile\/viswanadhapa\" rel=\"nofollow noopener\" target=\"_blank\">Suryavathi Viswanadhapalli, PhD<\/a>, associate professor in the Department of Obstetrics and Gynecology; and Hareesh B. Nair, PhD, associate professor at Texas Tech University Health Science Center, and previously senior director of discovery biology at Evestra, Inc. Nair is the lead inventor on LIFR inhibitor patent.<\/p>\n<p>They found that LIFR plays a critical role in driving tumor growth, metastasis and the survival of stem-like cancer cells that can resist therapy and contribute to recurrence. Early findings from the team suggest that blocking LIFR signaling may reduce cancer stem cell survival and restore sensitivity to radiation treatment.<\/p>\n<p>\u201cValidating LIFR as a therapeutic target could have a transformative impact,\u201d said Subbarayalu. \u201cIf we can sensitize osteosarcoma cells to radiation, we may be able to lower the required radiation dose while reducing long-term treatment toxicity for pediatric patients.\u201d<\/p>\n<p>Researchers believe successful completion of the study will provide strong preclinical evidence for advancing LIFR inhibitors into future clinical evaluation as a targeted therapy for osteosarcoma. The work represents a step towards developing stronger, more effective treatment options for osteosarcoma.<\/p>\n<p>To learn more about the Greehey Children\u2019s Cancer Research Institute, visit <a href=\"https:\/\/gccri.uthscsa.edu\/\" rel=\"nofollow noopener\" target=\"_blank\">gccri.uthscsa.edu<\/a>.<\/p>\n<p><a href=\"https:\/\/www.uthscsa.edu\/\" rel=\"nofollow noopener\" target=\"_blank\">UT Health San Antonio<\/a> is the academic health center of The University of Texas at San Antonio (UT San Antonio), offering a comprehensive network of inpatient and outpatient care facilities staffed by medical, dental, nursing and allied health professionals who conduct more than 2.5 million patient visits each year. It is the region\u2019s only academic health center and\u00a0one of the nation\u2019s leading health sciences institutions, supported by the schools of medicine, nursing, dentistry, health professions, graduate biomedical sciences and public health that\u00a0are leading change and advancing fields throughout South Texas and the world. To learn about the many ways \u201cWe make lives better\u00ae,\u201d visit <a href=\"https:\/\/uthscsa.edu\/?utm_source=uthealthsaorg&amp;utm_medium=pageredirect&amp;utm_campaign=uthealthsa\" rel=\"nofollow noopener\" target=\"_blank\">UTHealthSA.org<\/a>.<\/p>\n<p>Stay connected with UT Health San Antonio on <a href=\"https:\/\/www.facebook.com\/UTHealthSA\" rel=\"nofollow noopener\" target=\"_blank\">Facebook<\/a>, <a href=\"https:\/\/twitter.com\/uthealthsa\" rel=\"nofollow noopener\" target=\"_blank\">Twitter<\/a>, <a href=\"https:\/\/www.linkedin.com\/company\/uthealthsa\" rel=\"nofollow noopener\" target=\"_blank\">LinkedIn<\/a>, <a href=\"https:\/\/www.instagram.com\/uthealthsa\/\" rel=\"nofollow noopener\" target=\"_blank\">Instagram\u00a0<\/a>and <a href=\"https:\/\/www.youtube.com\/uthscsa\/\" rel=\"nofollow noopener\" target=\"_blank\">YouTube<\/a>.<\/p>\n<p><a href=\"https:\/\/cancer.uthscsa.edu\/gccri\" rel=\"nofollow noopener\" target=\"_blank\">The\u00a0Greehey\u00a0Children\u2019s Cancer Research Institute<\/a>\u00a0at UT Health San Antonio\u00a0is one of only two institutes in the United States dedicated solely to pediatric cancer research. Launched in 2004, the institute encompasses 18 laboratories, where researchers focus on cancer genomics, DNA repair, RNA\u00a0biology\u00a0and drug development for new and less-toxic treatments for childhood cancers.\u00a0UT Health San Antonio is the academic health center of The University of Texas at San Antonio (UT San Antonio).<\/p>\n<p>\t\t\t<script async src=\"https:\/\/platform.twitter.com\/widgets.js\" charset=\"utf-8\"><\/script><script async src=\"\/\/www.instagram.com\/embed.js\"><\/script><\/p>\n","protected":false},"excerpt":{"rendered":"Contact: Eileen Teves, 210-450-7239, tevese@uthscsa.edu SAN ANTONIO, June 30, 2026 \u2013 The American Cancer Society has awarded an&hellip;\n","protected":false},"author":2,"featured_media":356645,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8],"tags":[82,84,83],"class_list":["post-356644","post","type-post","status-publish","format-standard","has-post-thumbnail","category-san-antonio","tag-san-antonio","tag-san-antonio-headlines","tag-san-antonio-news"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/posts\/356644","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/comments?post=356644"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/posts\/356644\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/media\/356645"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/media?parent=356644"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/categories?post=356644"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us-tx\/wp-json\/wp\/v2\/tags?post=356644"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}